Zymeworks, Inc. (ZYME)
28.87
+0.02
(+0.07%)
USD |
NASDAQ |
Oct 28, 13:50
Zymeworks Price : 28.87 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 28.21 | 29.18 | 27.96 | 28.85 | 1.126M |
| Oct 26, 2026 | 28.36 | 28.59 | 27.59 | 28.37 | 833942.0 |
| Oct 23, 2026 | 28.77 | 28.77 | 27.28 | 28.22 | 1.124M |
| Oct 22, 2026 | 28.12 | 28.97 | 27.99 | 28.44 | 757350.0 |
| Oct 21, 2026 | 26.96 | 28.27 | 26.90 | 28.12 | 1.319M |
| Oct 20, 2026 | 25.76 | 27.20 | 25.71 | 26.91 | 3.130M |
| Oct 19, 2026 | 25.06 | 25.74 | 25.06 | 25.54 | 2.040M |
| Oct 16, 2026 | 25.67 | 25.86 | 24.94 | 25.03 | 632910.0 |
| Oct 15, 2026 | 25.19 | 26.21 | 25.18 | 25.75 | 751932.0 |
| Oct 14, 2026 | 25.00 | 25.20 | 24.60 | 24.77 | 558779.0 |
| Oct 13, 2026 | 25.04 | 25.60 | 24.92 | 25.07 | 2.455M |
| Oct 12, 2026 | 25.56 | 25.79 | 25.19 | 25.33 | 2.776M |
| Oct 09, 2026 | 25.28 | 26.34 | 25.28 | 25.79 | 491136.0 |
| Oct 08, 2026 | 26.24 | 26.24 | 25.00 | 25.26 | 1.367M |
| Oct 07, 2026 | 25.75 | 27.02 | 25.17 | 26.53 | 1.621M |
| Oct 06, 2026 | 26.42 | 26.79 | 25.51 | 25.65 | 1.466M |
| Oct 05, 2026 | 25.37 | 26.50 | 25.28 | 26.21 | 1.037M |
| Oct 02, 2026 | 26.18 | 26.19 | 25.04 | 25.15 | 844446.0 |
| Oct 01, 2026 | 26.44 | 26.56 | 25.88 | 25.96 | 808703.0 |
| Sep 30, 2026 | 27.25 | 27.73 | 26.47 | 26.49 | 1.585M |
| Sep 29, 2026 | 27.12 | 28.26 | 26.76 | 27.20 | 999905.0 |
| Sep 28, 2026 | 25.94 | 27.54 | 25.66 | 27.12 | 1.376M |
| Sep 25, 2026 | 26.86 | 26.88 | 26.22 | 26.52 | 1.095M |
| Sep 24, 2026 | 27.13 | 27.50 | 26.14 | 26.81 | 752934.0 |
| Sep 23, 2026 | 27.55 | 27.89 | 26.52 | 27.50 | 647748.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 287.53 |
| Aprea Therapeutics, Inc. | 0.5262 |
| ACADIA Pharmaceuticals, Inc. | 20.32 |
| Alnylam Pharmaceuticals, Inc. | 229.07 |
| Anika Therapeutics, Inc. | 21.49 |
Price Related Metrics
| PS Ratio | 58.09 |
| PEG Ratio | -0.1358 |
| Price to Book Value | 25.85 |
| Earnings Yield | -6.98% |
| Market Cap | 2.078B |
| PEGY Ratio | -0.1358 |